Lisraya wins dermatomyositis, but a boxed warning, a larger patient pool than advertised, and Phase 3 readouts define what the stock is actually worth.
Bitcoin is up about 22% in a month on Clarity Act momentum and a short squeeze. The Senate cloture vote is 19 days away, and the outcome is genuinely uncertain.